GSK caps big week for blocks with £1.3bn Haleon clean-up
GSK has fulled exited Haleon, enabling it to fully concentrate on its pharmaceuticals and vaccines business
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts